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Summary
Objective: To evaluate the feasibility of quantitative magnetic resonance imaging (MRI) based follow-up of cartilage volumetric data in patients
after autologous chondrocyte implantation (ACI). To provide results from a 1-year follow-up study.
Methods: From 21 ACI patients sagittal FS 3D FLASH (50/11/30; 0.6 0.6 1.5 mm3) MRI knee data sets were obtained pre and 1-year post-
ACI surgery in the femoral condyles. After semi-automated segmentation and 3D reconstruction of the cartilage plates, cartilage volume, mean
thickness and size of the cartilageebone interface were calculated. Susceptibility artifacts were evaluated in all, intra-observer reproducibility
was evaluated in six of the patients. Volumetric parameters were compared during follow-up and sensitivity to change was assessed for the
total femur vs the separately evaluated medial/lateral portions of the femur.
Results: Reproducibility error (coefﬁcient of variation %) was 3.9%/4.4% for the med./lat. tibial and 5.1% for the femoral cartilage volume. Sus-
ceptibility artifacts led to the exclusion of three out of the 21 patients, but were moderate in the remaining 18 patients, not preventing repro-
ducible segmentation. In contrast to lack of signiﬁcant change in the (non-operated) tibiae, a mean 6% increase of volume and thickness in the
treated femora (P< 0.001 Wilcoxon) relative to the pre-OP data was observed. Sensitivity to change for the femur ranged from 0.74 to 2.60 for
cartilage volume and thickness and was improved when evaluating only the treated portion of the femur in contrast to the total femur.
Conclusion: Our data indicate that despite postoperative susceptibility artifacts quantitative evaluation of cartilage volumetric parameters can
be performed in ACI patients. The technique is able to describe changes of these parameters over 1 year. Volumetric follow-up may help to
identify altered disease progression.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.





Damage to articular cartilage leading to defective articular
surfaces is considered to be a precursor of osteoarthritis
(OA), a major socio-economic burden today1e3. Autologous
chondrocyte implantation (ACI) as one of the comparatively
new techniques is designed to repair joint cartilage defects
in order to restore an intact and smooth joint surface4e6 with
the aim to prevent the development of OA and eventually to
stop the progression of preexisting OA. The technique con-
sists of harvesting autologous cartilage from a non-weight
bearing joint surface area and culturing chondrocytes
derived from this tissue sample. Subsequently, the cultured
chondrocyte suspension is injected into a cartilage defect
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2007.7which has been prepared by debridement and then the
defect area is covered, e.g., by a periosteal ﬂap7,8.
Mostly, success of the ACI procedure is determined from
clinical observations9e15 including second look arthroscopy
and histology16e18 as well as magnetic resonance imaging
(MRI) studies18e22. Due to the fact, that ACI is a new tech-
nique, data from long-term follow-up studies are not abun-
dant. The experience that is available from qualitative MRI
studies aims at demonstrating defect ﬁlling, integration of
the repair tissue or reconstitution of a smooth joint
surface18e22 at follow-up.
In contrast to this local assessment, a more global
approach targeted at quantifying the evolution of volume
and thickness of the femoral and tibial cartilage plates as
a whole may provide additional insight in the long-term
effectiveness of ACI. Cartilage volume and thickness and
their (annual) rate of loss have been observed to be asso-
ciated with early and advanced OA23e30. T1-w Fat Sat
and Water Excitation 3D FLASH sequences have been
validated for cartilage volume and thickness quantiﬁca-
tions24, 31e36 by comparison with computed tomography-
arthrography and anatomical sections for healthy98
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trieved during total knee arthroplasty in OA patients. For
healthy cartilage agreement between MRI and other
methods is within 4% for all cartilage plates33. In OA carti-
lage, the data show an underestimation of 10% in cartilage
volume as compared to water displacement24. Studying the
rate of cartilage volume and thickness change per unit time
may hold potential to contribute to the evaluation of ACI
treatment outcome because it may show very subtle (in
the order of magnitude of about 100 ml) changes of volume
and thickness25,27e30 which may not be detected in routine
MRI scans. This approach would come into play once the
technical success of the ACI procedure in terms of ongoing
of the graft, reconstitution of a smooth joint surface by ﬁlling
of the initial defect and integration of the graft into the neigh-
boring bone and/or cartilage is established. In this situation,
it could constitute a measure to evaluate the effect of ACI
on total (global) joint surface cartilage preservation by
assessing the annual rate of cartilage loss in both, the
treated as well as in the untreated joint compartments.
Yet, to date, there is no experience at all from quantitative
MRI evaluation of cartilage volumetric parameters in ACI
patients and it is not clear whether the technique can be
successfully applied to follow ACI patients: reproducibility
data are available only from healthy, untreated or non-oper-
atively treated subjects24,31,35,37e42 and sensitivity to
change as well as the inﬂuence of potential post-OP
susceptibility artifacts presumably due to debris from the
metallic instruments used during the procedure is unclear.
Therefore, the purpose of the study is (I) to assess the
feasibility of 3D volume and thickness measurements after
ACI. This comprises (1) extent and inﬂuence on cartilage
segmentability of susceptibility artifacts in post-OP data
sets, (2) post-OP resegmentation precision and (3) sensitiv-
ity to change of volumetric assessment. (II) To give ﬁrst
results of cartilage volume evolution in the treated and in
the untreated femoral and tibial joint compartments from
a 1-year follow-up period.
Patients and methods
A total of 21 patients (seven females, 14 males) were
investigated in this pilot study. Mean age was 36.3 7.7
years (median 39.3 years, range 25e48 years), mean
body weight was 79.1 14.9 kg (median 81.5 kg, range
55e105 kg). All patients gave informed consent for the
study. All patients had undergone ACI for cartilage loss
due to either OA or osteochondral defects with concomitant
OA in one femoral condyle (11 medial condyles, 10 lateral
condyles). Defect size (length by width in mm) measured
after surgical debridement was 23.0 6.5 mm (range:
10e38 mm) by 20.7 6.3 mm (range: 13e30 mm). Assum-
ing an elliptical shape of the operatively debrided defects,
their cross-sectional area was calculated as length/
2width/2p yielding an average defect size of 3.7
1.5 cm2 (range: 1.2e7.5 cm2). Defects were located in
the anterior third (3 out of 21), intermediate third (10 out
of 21) and posterior third (8 out of 21) of the femur. ACI
was performed in a two stage surgery. After harvesting
of cartilage from low weight bearing sites in the femoral
notch or the periphery of the femoral trochlea and chon-
drocyte culturing, the chondrocyte cell suspension was
injected under a periosteal patch covering the debrided
defect.
In all patients 1.5-T MRI (Magnetom Vision, Siemens-
Erlangen, Germany) using a circularly polarized knee coilwas performed within 1 week before and again between 1
and 1.7 years after operation. Board ethics review was ob-
tained prior to the study. Average time between the two im-
aging sessions was 14 2 (median 13, range 12e21)
months. For volumetric evaluation a 3D FLASH fat presatu-
rated sequence (repetition time: 50 ms/echo time: 11 ms/ﬂip
angle: 30) was applied using a ﬁeld of view (FOV) of
162 cm2 or 182 cm2, respectively, a 2562 matrix and a
slab of 90 mm composed of 60 sagittal partitions of 1.5 mm
each. Spatial resolution was 1.5 (0.6252 or 0.7052) mm3.
Similar sequences applying fat presaturation or water excita-
tion techniques with spatial resolutions ranging from
1.5 0.32 to 2 0.6 0.8 mm3 have previously been vali-
dated for 3D knee cartilage volumetric assessment24,31e36.
A sagittal orientation was chosen to completely cover all
knee joint cartilage plates. Care was taken to obtain a truly
sagittal and as such reproducible section orientation of the
slab perpendicular to a tangent line to the most posterior
border of the femoral condyles in axial sections.
For 3D evaluation, semi-automatic segmentation using
a b-spline snake algorithm with interactive visual control
of the cartilage was performed (one experienced segmen-
tator) for the distal femoral cartilage plate and the medial
and lateral tibial plateau, separately and subsequently,
3D reconstruction of the cartilage plates was performed
after interpolation to isotropic voxels42,43. As global param-
eters cartilage volume (voxel count), 3D mean cartilage
thickness as well as the distribution of local cartilage thick-
ness (thickness plot, Euclidean distance transformation)
and the size of the cartilageebone interface were
calculated for each joint surface44, 45. Areas of complete
cartilage loss were included in thickness calculation as
areas of 0 mm thickness. In cases with difﬁcult delineation
between cartilage and joint effusion, a T2-w DESS
sequence was used to visually support segmentation.
Values were compared between pre- and post-OP data
sets (Fig. 1). In addition, interactive segmentation of the
cartilage defect was performed and the defect’s volume
and surface area were determined from the pre-OP data
set after 3D reconstruction using the algorithm described
above42, 43. Surface area was deﬁned as the size of the
(former, intact) joint surface that was destroyed by the
defect. The beginning/end of a defect was visually deﬁned
as a markedly increased curvature of the femoral cartila-
ge’s (convex) surface followed by a surface concavity in
a not anatomical location. The former joint surface was
interactively extrapolated from the adjacent intact cartilage.
The exact border of a defect was deﬁned as the point of
separation between the extrapolated joint surface and the
actual cartilage surface contour.
The reproducibility of intra-individual segmentation was
assessed in six randomly chosen patients’ postoperative
data sets by four consecutive segmentations in each femo-
ral and tibial data set38. Reproducibility was determined for
segmentation of the total femoral cartilage, for the sepa-
rated medial/lateral portion (see description in last para-
graph) of the femur and for the segmentation of the
cartilage defects. There was a delay of at least 2 weeks be-
tween each of the four consecutive segmentation pro-
cesses. The reproducibility error was calculated as the
root mean square average of the coefﬁcient of variation
(COV) in each individual patient31,35,37e39,41.
The severity of postoperative susceptibility artifacts was
rated in order to assess whether these artifacts affected
image quality to an extent relevant for cartilage segmenta-
tion. Rating was performed by two radiologists (CG, CT)
in consensus. Artifacts were deﬁned as areas of signal
800 C. Glaser et al.: Feasibility of quantitative MRI of autologous chondrocyte implantationFig. 1. (aef) Image post-processing. The cartilage is segmented on a semi-automated basis (a: pre-OP, b: post-OP) in the original
MR-sections. Subsequent to interpolation to isotropic voxels the cartilage plate is reconstructed in 3D and the global parameters as well
as the local 3D thickness distribution (c: pre-OP, d: post-OP) are calculated. Low thickness values are encoded in red, high thickness values
in white or green. For the separation of the medial and lateral portions of the femoral cartilage plates the shortest cartilage covered length,
i.e., depth of the trochlear groove, was taken as landmark, illustrated in a different patient (e,f).void in or adjacent to the cartilage. Five categories were
deﬁned according to the extension of the signal void relative
to the cartilage boundaries ranging from minimal (0) to
severe (4). Minimal artifacts were deﬁned as small
(<5 mm) purely intracartilaginous foci without any contact
to the cartilageebone interface or the surface of the carti-
lage. Severe artifacts were deﬁned as areas of signal void
exceeding the thickness of the cartilage and being continu-
ous over more than 10 mm, thus preventing reliable delin-
eation of the cartilage contours and leading to exclusion
of this data set from evaluation. Table I summarizes the
details of the rating scale, Fig. 2 illustrates the various
grades of artifacts. In addition, the share (given in %) of
the former defect’s cartilaginous surface which was ob-
scured by artifact was calculated (Fig. 3). This was
achieved by segmentation of those artifacts obscuring the
cartilage surface in the post-OP data sets, calculation of
their surface area and normalization to the total surface of
the defects segmented in the corresponding pre-OP data
sets. Similar to the pre-OP data sets, in areas of the repair
site where cartilage repair tissue was obscured by artifacts,
the surface was extrapolated visually from the adjacent joint
surface not affected by artifacts. The portion of artifact be-
tween the extrapolated cartilage surface and the subchon-
dral bone was considered to be cartilage.
In a subset of 10 patients, additionally, evaluation was
performed separately for the medial/lateral portions of the
femoral cartilage plate including the medial/lateral portions
of the trochlea and condyles. The anatomic landmark for
separating the medial and lateral portions of the distal femurwas the shortest cranio-caudad extension of the cartilage in
the trochlear groove in the original sections (Fig. 1). Based
on the assumption that the size of the cartilageebone inter-
face does not undergo relevant changes within 1 year,
separation was accepted within a delta of 5% between
pre- and post-OP data for the size of the cartilageebone
interface segmentations. Sensitivity to change for volume,
thickness, cartilageebone interface and volume normalized
to the size of the cartilageebone interface was estimated in
this subset of 10 patients by comparing the standardized
response means (SRM¼mean change/standard deviation
of change) between total femur and the separated med./
lat. portions of the femur. It was calculated for the relative
(%) change to baseline for volume and thickness.
Results
Average artifact grading was 1.8 for all patients. In all but
three of the data sets relevant postoperative artifacts were
present. Artifact grading led to exclusion of three out of
the 21 patients’ data sets from further evaluation due to
severe artifacts preventing reliable segmentation. In the
remaining 18 data sets, average rating was 1.4. A total of
16 out of these 18 were rated as intermediate or better
(Table I). The mean share of the former defects’ surface
area covered by artifact was 9.3% for artifact grades
0 through 3 (Fig. 3). There was an abrupt increase in the
surface area covered by artifact from 21.3% for artifact
grade 3e69.3% for artifact grade 4 (Fig. 3). Linear
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obscured by artifact was good with R2¼ 0.73, P< 0.001.
Morphologically, there was considerable variability of the
outcome of the ACI procedure with only partial ﬁlling of the
former defect in three patients, good reconstitution of
Table I
Rating of susceptibility artifacts: rating scale ranges from ‘0’ mini-
mal to ‘4’ severe, preventing reliable segmentation. Criterion for
the grading was the extent of the signal void relative to the cartilage
layer and its boundaries




0: Minimal 3 No contact to cartilage boundaries
1: Moderate 7
Mean (grade 1e3): 1.72: Intermediate 6
3: Strong 2
4: Severe 3 Excluded from segmentation
Artifact rating scale
0: Minimal Small (<5 mm maximal extension)
intracartilaginous foci of signal void
1: Moderate Small (<5 mm) intracartilaginous foci of signal
void with contact to either the cartilageebone
interface or the cartilage surface
2: Intermediate Larger (>5 mm but <10 mm maximal extension)
intracartilaginous foci of signal void with contact
to either the cartilageebone interface or the
cartilage surface
3: Strong Larger (>5 mm but <10 mm) intracartilaginous
foci of signal void with focal contact to both,
the cartilageebone interface and the cartilage
surface
4: Severe Foci of signal void exceeding the thickness of
the cartilage with a continuous extension parallel
to the cartilage layer of more than 10 mm
The severity of postoperative metal-induced artifacts prevented
reliable segmentation in 3 out of the 21 data sets. However, artifact
severity was considered acceptable in 18 of the 21 patients. Among
those 18 data sets, 16 were rated intermediate or better. Average
rating in the 18 segmented data sets (grade 0e3) was 1.4.a smooth articular surface in nine patients and considerable
graft or periosteal overgrowth in six patients. Partial ﬁlling
was characterized by reduced cartilage thickness in the
region of the defect as compared to the adjacent cartilage
and by a more irregular surface contour. Conversely,
overgrowth showed higher regional thickness values and
some degree of bulging of the cartilage surface contours.
From the MRI sequence, differentiation between perios-
teum and cartilage repair tissue was not possible.
Reproducibility error (COV) as calculated from the repeat
segmentations ranged from 3.7% to 5.6% with highest
values for the femur (Table V). Reproducibility error for
the separated portions of the femur ranged from 6.1% to
7.9% (Table V). Reproducibility error for defect volume
and defect surface area was 14.7% and 9.3%.
A total of 15 out of 18 patients had a nominal increase in
femoral cartilage volume (þ0.3eþ9.9%). Three out of 18
patients had a nominal reduction in femoral cartilage
volume (0.4% to 2.5%). Average total femoral volume
increase was 1.04 0.69 ml corresponding to 5.8% (Table II,
Fig. 2). No such tendency could be observed for the
cartilageebone interface in the femora as well as in the
tibiae. There was a small nominal, statistically not signiﬁ-
cant (P> 0.05; Wilcoxon signed rank test), tendency to
lower cartilage volume and thickness values (0.3% for
volume and 1.6% for thickness) over the 1-year period
in the tibiae. Fourteen out of 18 patients had a reduction
of medial tibial cartilage volume/thickness (0.3% to
6.9%), four had an increase (0.3e6.8%). Eleven out of
18 patients had a reduction of lateral tibial cartilage
volume/thickness (0.1% to 5.1%), seven had an
increase (0.5e4.8%). Standard deviations, mean and range
of values are given in Table II. Average femoral defect vol-
ume based on the preoperative MRI was 0.67 0.35 ml
(range: 0.15 ml to 1.32 ml). Average defect surface area
based on the preoperative MRI was 281.5 154.9 mm2
(range: 88.9e653.7 mm2).
In the subset of 10 patients in whom volume and thickness
were calculated separately for the medial/lateral portions of
the femur, the absolute increase of cartilage volume/thick-
ness in the operated portion of the femur was comparableFig. 2. (aee) Examples of artifacts for each grade: grade 0 (a), grade 1 (b), grade 2 (c), grade 3 (d) and grade 4 (e), compare also Table I.
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the complete study population (Table III). This resulted in
a higher relative increase of volume and thickness from
pre-OP to post-OP data for the operated femoral cartilage
portions (Table III, Fig. 2) than for the total femur. The change
in volume/thickness increased from 5.8%/6.4% (total femur)
to 9.3%/13.8% (medial condyle operated). As for the total fe-
mur (0.1%) therewas no substantial change (0.93%medial
femur/1.1% lateral femur) in the size of the cartilageebone
interface. Volume increase in the operated portion of the fe-
mur over 1 year was 0.82 0.47 ml. Mean defect volume in
this subset was 0.71 0.40 ml.
SRMs for volume and thickness ranged from 0.74 to 2.60
(Table IV). Separate evaluation of the operated portions
of the femur in contrast to the total femur substantially
improved sensitivity to change (SRM) for cartilage thickness
(Table IV). The average rate of improvement was 58%
(range 26e81%). There was only minor improvement of
SRM for cartilage volume when comparing the operated
femoral portions with the total femur. There was no relevant
inﬂuence of comparing the operated femoral portions with
the total femur on the sensitivity to change of the cartila-
geebone interface as well as of volume normalized to the
cartilageebone interface (Table IV). Sensitivity to change
(SRM) for volume and thickness generally was lower for
the medial (0.98 and 0.93) than for the lateral (2.60 and
1.34) femoral condyle.
Fig. 3. Boxplot of % surface area covered by artifact with subgroups
as deﬁned by rating scale. The encircled cross symbol corresponds
to the mean, the horizontal line to the median value of each sub-
group. Values show a clear increase of the percentage of the car-
tilage surface obscured by artifact from grade 3 to grade 4.Discussion
The purpose of this study was to assess the feasibility
of quantitative longitudinal volumetric evaluation of the
cartilage in ACI and to give ﬁrst 1-year follow-up results.
To this end, the inﬂuence of susceptibility artifacts, the
reproducibility of segmentation of the post-OP measure-
ments and the ability to show change over time are of
interest.
Gradient echo (GRE) sequences as the MRI-sequences
currently used for quantitative volumetric evaluation of
cartilage are comparatively susceptible to local alterations
in main magnetic ﬁeld strength. When too extensive, sus-
ceptibility artifacts might prevent reliable image evaluation.
Although the exact reason of such artifacts is still unclear
and for better prevention investigation into their cause is
needed, use of non-metallic, plastic tipped suckers and
non-metallic ceramic tipped surgical tools in the future
may contribute to reduce such artifacts in MRI. However,
rating of susceptibility induced signal voids in average
revealed but moderate artifacts (mean rating: 1.8 out of
max. 4 possible) allowing for segmentation in 18 out of 21
data sets. In 14% (3/21) of the data sets artifacts extended
over a length of more than 10 mm and prevented reliable
segmentation. In all these cases, the artifacts were so ex-
tensive that they would have impaired reliable local clinical
assessment of the cartilage in the GRE sequences used in
this study, too. However, ACI artifacts rarely are observed
to such an extent in turbo spin echo (TSE) sequences.
Therefore, routine clinical (visual) analysis would proﬁt
from acquisition of such TSE sequences in addition to
GRE sequences. The high increase in the surface area of
cartilage defects covered by artifact (Fig. 3) from 21.3%
(grade 3) to 69.3% (grade 4) suggests that this transition
is a reasonable cutoff value to decide upon acceptability
of artifact grading for segmentation. The observed drop
out rate in this pilot study constitutes a ﬁrst estimate and
may contribute to plan studies for quantitative evaluation
after ACI.
The slab of 90 mm width (60 sagittal partitions at 1.5 mm)
provided complete coverage of all articular joint surfaces
in the examined knees. Defect locations were distributed
mostly within the intermediate and posterior portions of
the femoral condyles. Therefore, and despite a potential
improvement of reproducibility from coronal section orienta-
tion in the tibiae and the central portions of the femur40,
a sagittal section orientation has been chosen in order to
enable complete assessment of all defects. Unfortunately,
the FOV varied between 162 cm2 and 182 cm2, possibly
contributing to the observed precision error in this study.Table II
Total femoral and medial/lateral tibial cartilage volumetric data. Standard deviation and range of values are given in small characters. There is
a slight increase in total femoral cartilage volume and thickness (P¼ 0.00009 and 0.00014; Wilcoxon signed rank test. The size of the femoral
cartilageebone interface and all tibial parameters show no significant change from pre- to post-OP data (P> 0.05; Wilcoxon signed rank test)
Cartilage plate Pre-OP vs post-OP volumetric data: total femur, medial/lateral tibia (n¼ 18)
Volume (ml) Mean thickness (mm) Cartilageebone interface (mm2)
Pre Post Pre Post Pre Post
Femur Vol SD 17.0 4.08 18.1 4.1 1.7 0.3 1.9 0.1 6706 961 6721 1022
Range 9.4e25.6 10.8e26.0 1.2e2.4 1.4e2.6 5120e8838 5126e8516
Medial tibia Vol SD 2.4 0.7 2.4 0.7 1.3 0.3 1.3 0.3 1211 216 1206 234
Range 1.2e4.2 1.1e4.0 0.9e2.0 0.9e1.9 694e1739 705e1777
Lateral tibia Vol SD 2.9 0.7 2.9 0.7 1.7 0.3 1.7 0.3 1217 223 1199 196
Range 1.4e4.3 1.4e4.2 1.3e2.2 1.2e2.3 646e1707 670e1561
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Volumetric data of subgroups (10 patients: five medial femoral condyle operated, five lateral femoral condyle operated) given for the medial/
lateral portions of the separated femoral cartilage plates and medial/lateral tibiae. The values are given depending on which portion of the
femoral condyle (med/lat) was operated. Standard deviation is given in small characters
Subgroup according
to cartilage plate
Pre-OP vs post-OP volumetric data: separated medial/lateral femur (n¼ 10)
Volume (ml) Mean thickness (mm) Cartilageebone interface (mm2)
Pre Post Pre Post Pre Post
Med femur,
med cond operated
8.49 1.75 9.26 2.02 1.67 0.21 1.92 0.47 3325 243 3295 260
Lat femur,
lat cond operated
10.24 1.45 11.13 1.36 1.96 0.28 2.15 0.23 3820 269 3868 427
Med femur,
lat cond operated
9.02 3.40 9.14 3.04 2.03 0.47 1.99 0.31 3172 776 3159 772
Lat femur,
med cond operated
9.02 1.62 9.22 1.79 1.94 0.34 1.96 0.39 3360 238 3394 292
Med tibia,
med cond operated
2.34 0.85 2.31 0.84 1.27 0.30 1.20 0.30 1190 262 1182 270
Lat tibia,
lat cond operated
2.86 0.93 2.79 0.90 1.69 0.26 1.57 0.32 1242 328 1225 278
Med tibia,
lat cond operated
2.40 0.69 2.37 0.67 1.36 0.37 1.33 0.37 1177 233 1173 241
Lat tibia,
med cond operated
2.85 0.73 2.81 0.72 1.72 0.32 1.70 0.36 1178 208 1144 195
cond ¼ condyle.
In contrast to the tibiae and the non-operated portion of the femur, there is a clear increase in volume and thickness in the operated portions
of the femoral condyles in each group. There was no change in the size of the cartilageebone interface in any of the cartilage plates.The precision of segmentation has been determined
as intra-observer reproducibility errors. Ethical permission
was not obtained for a second data acquisition precluding
a testeretest design for evaluation of reproducibility. In
addition to segmentation errors, a testeretest design would
incorporate partial volume averaging, which may be relevant
especially with respect to the presentation of post-OP
artifacts in various imaging sessions. A testeretest
design could provide information whether the grading of
any given artifact stays constant or whether there is tran-
sition from one grade to another grade in different
imaging sessions possibly affecting the cumulative drop
out rate. This, as well as the lack of inter-observer repro-
ducibility is a limitation of this study. The results (femur
and tibiae) between 5.1% and 3.9% are within the order
of magnitude described in previous studies for sagittal
Table IV
Sensitivity to change calculated as the SRMs (SRM ¼mean
change/standard deviation of change). Change is given for the rel-
ative (%) difference (post-OPepre-OP) relative to pre-OP values



























Volume 1.53 1.39 0.98 2.60 1.40 1.40
Thickness 1.17 0.74 0.93 1.34 0.74 0.78
Interface 0.06 0.16 0.77 0.25 0.10 0.20
Vol/
interface
1.24 1.19 0.87 1.60 1.21 1.19
Especially cartilage thickness proﬁts from separate evaluation of
the operated portion of the femur, whereas there is only minor proﬁt
for cartilage volume. Expectedly, SRM for the cartilageebone inter-
face is low.sections in both, volunteers and OA patients. They are
reported to be within 1.5e3.9%31,37,41 for the femur and
within 2.1e4.2%37,38,41 for the tibiae in healthy volunteers.
In patients with defective cartilage the values for reseg-
mentation conditions are between 2.9% and 3% for the
femur and between 3.2% and 7.1% for the tibia31,39. Ac-
cording to the results of Hardy et al.46 reproducibility error
is likely to increase with decreasing in plane resolution
from 0.282 mm2 to 0.552 mm2. The slightly lower
reproducibility values, present in this study for the femur
are commonly attributed to the higher degree of curvature
perpendicular to the orientation of the MRI partitions in
the femoral condyles as compared to the tibial plateaus.
Sensitivity to change assessed as SRMs generally was
higher for volume than for thickness (Table IV). This may
be explained by the fact that mean thickness is calculated
from thousands of local thickness values all over the re-
spective joint surface. Consequently, the local increase of
thickness due to ﬁlling of a treated focal defect may show
but a comparatively smaller effect on mean thickness as
a global parameter.
Separation of the two portions of the femur increased the
sensitivity to change (Table IV). Expectedly, this also is
expressed in the higher relative rate of change in volume
and thickness (9% and 13% vs 6%) for the separately
evaluated medial/lateral portions of the femur (Fig. 4) as
a comparable absolute change is normalized to a smaller
base value. It appears, that this effect is higher than the
additional inaccuracy which is introduced by the process
of separating the femur (Table V). Separation of the femur
was performed in the original MRI data sets in 2D and is
consequently prone to bias due to inconsistent positioning
of the patients. This is to bedand could bedminimized
by a strictly standardized positioning scheme of the slabs/
sections which was followed in this study. The cutoff value
(5%) for the delta between pre- and postoperative bone
cartilage interface which is mainly based on the intra-reader
reproducibility for the femur (5.1%), thus, seems
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dyles only (instead of med./lat. portion of the femur) may
provide an additional increase of sensitivity to change. How-
ever, lesions located more anteriorly in the femur may in
part extend to portions of the trochlea and then could not
be fully evaluated. Moreover, although desirable, direct sep-
aration of the femur (or femoral condyles) in 3D after seg-
mentation and reconstruction of the complete femoral
cartilage plate is still hampered by lack of appropriate
software.
Interestingly, the gain in sensitivity to change was much
more important for cartilage thickness whereas mixed
results (clear improvement only for lateral femur) were
obtained for cartilage volume (Table IV). This too, may
reﬂect the above mentioned issue of patient positioning
and separation of the femoral cartilage plate which implies
an interactive step by the segmentator. This process may
be more problematic for the medial femoral condyles37.
The parameter volume results from both, the segmented
Table V
Resegmentation precision error calculated as COV (%) from four
consecutive segmentations in six patients’ post-OP data sets.
The higher values for femoral data probably are related to the
higher degree of curvature in the femur as compared to the more
even tibial plateaus
Reproducibility error (COV [%])
Volume Mean thickness Cartilageebone
interface
Total femur 5.1 5.6 4.6
Medial femur 7.9 5.9 6.4
Lateral femur 6.7 7.2 6.1
Medial tibia 4.4 4.2 3.7
Lateral tibia 3.9 4.8 4.1
Fig. 4. Comparison of the percent change in cartilageebone inter-
face (Area), volume (Vol) and mean thickness (mD) pre-Op to
post-OP in a subset of 10 patients: total femur (tf) vs operated
portions of femur and corresponding tibial plateaus. Mfma¼medial
femur when medial femoral condyle was operated; lﬂa¼ lateral
femur when lateral femoral condyle was operated; mﬂa¼medial fe-
mur when lateral femoral condyle was operated; lfma¼ lateral
femur when medial femoral condyle was operated; mt¼medial
tibia; lt¼ lateral tibia. There was an average increase of cartilage
volume and mean thickness from pre- to post-OP data of 6% in
contrast to the (expected) absence of change in the size of the car-
tilageebone interface for the total femur. In contrast, there was
a tendency to volume and thickness loss of 1e3.5% in the tibial pla-
teau. Note the higher percentage change in the operated portions
of the femur being 9% for volume and 10e13% for thickness.area of the cartilageebone interface and the segmented
cartilage thickness. Both, cartilageebone interface area
and cartilage thickness are described as (independent)
determinants of cartilage volume25,45,47,48. Consequently,
in the case of subdividing a joint surface, the parameter
mean thickness is less likely to be compromised by small
variations of the segmented area of the cartilage plate
than would be volume.
Normalization of cartilage volume to the cartilageebone
interface area has been shown to yield higher discriminatory
power in a cross-sectional study using a T-score system
as a means to detect OA related changes in patients
with varus/valgus misalignment alone and prior total
knee arthroplasty23. In this study, normalization of volume
to cartilageebone interface yielded SRM values comparable
to volume and mean thickness, but there was no noticeable
change following separation of medial and lateral femur.
Thus, overall, normalization of volume to cartilageebone
interface did not affect the sensitivity to change (SRM)
in our study (Table IV).
At present, the thickness plot projected over the 3D
reconstruction of the cartilage plate gives a qualitative
means to roughly control the success of therapy and it
may be helpful in systematically assessing the location of
the defects within the joint surface. It would be intriguing
to perform pixel by pixel comparison of preoperative and
follow-up data as then a much more precise analysis could
be done. However, this requires an elastic matching or
other coregistration techniques49e51 of the reconstructed
surfaces with a precision error of not more than the
dimensions of one pixeldwhich is not available from the
literature yet.
The values for cartilage volume and thickness in our
patient group overlap with values from the literature for
patients and healthy volunteers33,52e55 showing high inter-
individual variability consistent with ﬁndings in several
studies identifying bone size as an important determinant
of cartilage volume in the knee45,47,48,52,56. Differences of
volume/thickness amount to up to 38%/47% as compared
to those observed in young healthy volunteers47.
Individual cartilage volume/thickness differences showed
a continuum suggesting that a relevant range of disease
severity was covered by the study group.
With 1.04 ml and 0.82 ml femoral cartilage volume
increase in the 1-year follow-up period was slightly but not
statistically signiﬁcantly higher than pre-OP defect volume
(0.67 ml and 0.71 ml) for both, total and separated femur.
On the one hand, this is consistent with the higher number
of patients showing overgrowth (n¼ 6) than those showing
partial ﬁlling (n¼ 3), a phenomenon that has been reported
previously21.
On the other hand, MRI derived defect surface area was
smaller than debrided defect cross-sectional area. This may
be attributable to surgical excision of softened cartilage in
the periphery of the defect showing (near to) normal
appearance in MRI suggesting some underestimation of
defect size by MRI in this study. Compositional MR imaging
studies such as dGEMRIC or T2 mapping may be beneﬁcial
in view of both, pre-OP defect and post-OP repair evalua-
tion but were beyond the scope of this study. Moreover,
defect segmentation is conceptually difﬁcult requiring
assumptions about the original position of the cartilage
surface which introduce additional variability in the evalua-
tion. Also, partial volume averaging will have higher impact
on the small defects as compared to the larger joint surface.
This is reﬂected by the higher precision errors calculated for
defect surface area and volume amounting up to 9% and
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orientation on the plausibility of globally measured changes,
to our opinion, the strength of volumetric evaluation is rather
in global joint assessment of cartilage loss/repair.
Comparing femoral and tibial cartilage volume follow-up,
most of this increase seems attributable to the ingrowth of
cartilage into the defect. The amount of this increase is
high compared to reported loss of cartilage in OA25, 27e30.
The reported amount of annual femoral cartilage volume
change in OA is 104 324 ml (corresponding to
0.8 2.4%) for the total femur54 and 150 250 ml (cor-
responding to 7.6 8.4%) for those portions of the femur
considered to represent its contributions to the medial or
lateral femoro-tibial joints27. This, lastly, can be expected
froma technically successful ACI procedurewith graft growth
and integration once a ﬁrst critical period for the graft tissue
(3e9 months to 1 year) is overcome13,14,17,18,21,57,58.
Although these data suggest that within 1 year most of
the cartilage volume increase due to the ACI procedure
can be expected, hypertrophy as well as complete defect
ﬁlling59 may occur later than 1 year. This illustrates that
interpretation of global data including the area of the oper-
ated defects is problematic, because competing processes,
i.e., growth of repair tissue on the one hand and potential
decrease of native cartilage due to progression of OA on
the other hand, are to be taken into account. An option
that may contribute to at least reducedsurely not to
completely resolvedthis uncertainty in interpretation, could
be, to qualitatively (in addition to the quantitative measure-
ments) evaluate the graft area for presence of hypertrophy
(and incomplete ﬁlling) as potential confounding factors.
Nonetheless, according to Henderson et al.59 more than
90% of grafted areas evaluated showed near complete or
complete ﬁlling59 after one year. Therefore, our 1-year
follow-up data might be helpful to determine whether a tech-
nically successful ACI procedure contributes to slow the
rate of femoral cartilage loss in OA in itself or whether there
is ongoing loss of femoral cartilage over a longer observation
time period which is only masked by the initial increase of
cartilage volume due to the ACI procedure.
In contrast to the femoral data, there was no signiﬁcant
longitudinal change in theduntreateddtibiae during the
1-year follow-up period. Ranging from þ0.4% to e1.8%
these changes were smaller than the reproducibility error
of this study. However, there was a tendency to smaller
values and more patients numerically had a reduction rather
than an increase of tibial cartilage volume and thickness as
compared to the femur. The absolute volume changes in
the tibiae varied between 10 and 70 ml. This amount of
change is smaller than those reported in the literature
from longitudinal studies in OA patients without (operative)
treatment. With the exception of one study where no signif-
icant change was reported54, those changes range from
3.5% to 8.4%, corresponding to 88e164 ml25,27e30. In
contrast to the femoral data, in the tibiae as non-operated
compartments, in OA cartilage volume and thickness are
expected to only decrease with time. Therefore, these
results may suggest a beneﬁcial effect of the ACI procedure
on cartilage loss, but may also be related to altered physical
activity during the post-OP period and lastly cannot be
differentiated from an incidental ﬁnding from this pilot study.
Interestingly, the evolution of medial and lateral tibial carti-
lage volume and thickness was uniform irrespective of
which (medial or lateral) femoral compartment was
operated.
Lack of a follow-up period longer than 1 year is a limitation
of this study and longer follow-up studies with controlpopulations are needed to determine if ACI can help slow
or prevent OA.
Conclusion
Our data suggest that quantitative volumetric analysis is
applicable to ACI patients. Susceptibility artifacts interfered
with segmentation to a variable degree in most patients, but
was judged to be severe enough to preclude quantitative
evaluation in only three patients (14%). Resegmentation
reproducibility errors are comparable to those in untreated
patients or volunteers. Separate evaluation of the operated
portion of the femur increased sensitivity to change. The
observed signiﬁcant increase of volume and thickness in
the treated femoral compartment may indicate the initial
increase of cartilage substance after a technically successful
ACI procedure anddalthough difﬁcult to interpretdcould
be used as a baseline to evaluate further evolution of
cartilage substance change. The lack of cartilage loss in
the tibiae may help to identify altered disease progression
after ACI.
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